S

Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399

Watchlist Manager
Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399
Watchlist
Price: 11.06 CNY -0.09%
Market Cap: 13.8B CNY
Have any thoughts about
Shenzhen Hepalink Pharmaceutical Group Co Ltd?
Write Note

Shenzhen Hepalink Pharmaceutical Group Co Ltd
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shenzhen Hepalink Pharmaceutical Group Co Ltd
Change in Working Capital Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
S
Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399
Change in Working Capital
-ÂĄ1.4B
CAGR 3-Years
-7%
CAGR 5-Years
-3%
CAGR 10-Years
-25%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Change in Working Capital
-ÂĄ332.3m
CAGR 3-Years
26%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Change in Working Capital
-ÂĄ1.1B
CAGR 3-Years
15%
CAGR 5-Years
-67%
CAGR 10-Years
-17%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Change in Working Capital
-ÂĄ15.1B
CAGR 3-Years
8%
CAGR 5-Years
-4%
CAGR 10-Years
-14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Change in Working Capital
-ÂĄ5B
CAGR 3-Years
-4%
CAGR 5-Years
7%
CAGR 10-Years
-7%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Change in Working Capital
-ÂĄ1.1B
CAGR 3-Years
-13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Shenzhen Hepalink Pharmaceutical Group Co Ltd's Change in Working Capital?
Change in Working Capital
-1.4B CNY

Based on the financial report for Jun 30, 2024, Shenzhen Hepalink Pharmaceutical Group Co Ltd's Change in Working Capital amounts to -1.4B CNY.

What is Shenzhen Hepalink Pharmaceutical Group Co Ltd's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
-25%

Over the last year, the Change in Working Capital growth was 12%. The average annual Change in Working Capital growth rates for Shenzhen Hepalink Pharmaceutical Group Co Ltd have been -7% over the past three years , -3% over the past five years , and -25% over the past ten years .

Back to Top